WALDEN UNIVERSITY
Midterm Exam NRNP6635 / NRNP 6635 (Latest 2026/2027):
Psychopathology and Diagnostic Reasoning - Walden 2026/2027
PSYCHOPATHOLOGY & DIAGNOSTIC REASONING - Official Exam 2026/2027
100 80% CERTIFIED
QUESTIONS PASSING SCORE RECERTIFICATION
TABLE OF CONTENTS
Section 1 Neurobiological Foundations of Psychopathology Q1-Q20
Section 2 Diagnostic Classification and DSM-5-TR Principles Q21-Q40
Section 3 Mood, Anxiety, and Trauma-Related Disorders Q41-Q65
Section 4 Psychotic, Substance Use, and Cognitive Disorders Q66-Q85
Section 5 Diagnostic Reasoning and Treatment Planning Q86-Q100
Instructions: Select the single best answer for each question. This exam is designed for NRNP 6635 Psychopathology
and Diagnostic Reasoning midterm examination. Passing score: 80% (80 questions correct).
Midterm Exam NRNP6635 / NRNP 6635 (Latest 2026/2027): Psychopathology and Diagnostic Reasoning - Walden 2026/2027 2026/2027 | Passing Score: 80% | Page 1 of 54
,Midterm Exam NRNP6635 / NRNP 6635 (Latest 2026/2027): Psychopathology and Diagnostic Reasoning - Walden 2026/2027 2026/2027 | Passing Score: 80% | Page 2 of 54
, SECTION 1 | Neurobiological Foundations of Psychopathology | Q1-Q20 | Midterm Exam NRNP6635 / NRNP 6635 (Latest
2026/2027): Psychopathology and Diagnostic Reasoning - Walden 2026/2027 2026/2027
Q1 Question 1 of 100
A 34-year-old male presents with persistent auditory hallucinations and disorganized speech. His PMHNP reviews
the neurobiological underpinnings and recalls that dopamine overactivity in which pathway is most directly linked
to positive psychotic symptoms?
A. Mesolimbic pathway
B. Nigrostriatal pathway
C. Mesocortical pathway
D. Tuberoinfundibular pathway
Correct Answer: A
Rationale:
The mesolimbic pathway, projecting from the ventral tegmental area to the nucleus accumbens, is the primary
dopaminergic circuit associated with positive psychotic symptoms such as hallucinations and delusions. The
nigrostriatal pathway regulates motor control and its blockade causes extrapyramidal symptoms, not psychosis
reduction.
Q2 Question 2 of 100
A 28-year-old female with major depressive disorder has not responded to two adequate SSRI trials. Her PMHNP
considers the neurobiological rationale for switching to a serotonin-norepinephrine reuptake inhibitor. Enhanced
norepinephrine activity in the locus coeruleus is most associated with which clinical improvement?
A. Improved energy and concentration
B. Decreased appetite and weight loss
C. Reduction in suicidal ideation
D. Resolution of insomnia
Correct Answer: A
Rationale:
Norepinephrine produced in the locus coeruleus plays a central role in arousal, alertness, and cognitive focus.
Enhancing NE transmission improves energy, motivation, and concentration, which are often impaired in depression.
Appetite changes are more linked to serotonin and histamine pathways.
Midterm
Midterm
Exam
Exam
NRNP6635
NRNP6635
/ NRNP
/ NRNP
6635
6635
(Latest
(Latest
2026/2027):
2026/2027):
Psychopathology
Psychopathology
andand
Diagnostic
Diagnostic
Reasoning
Reasoning
- Walden
- Walden
2026/2027
2026/2027
2026/2027
2026/2027
| Passing
| Passing
Score:
Score:
80%80%
| Page
| Page
3 of3 54
, Q3 Question 3 of 100
A 42-year-old male with generalized anxiety disorder is being evaluated by his PMHNP. The patient asks why
benzodiazepines reduce anxiety so quickly. The PMHNP explains that benzodiazepines enhance the effect of
GABA by binding to which site on the GABA-A receptor?
A. The benzodiazepine allosteric site, increasing chloride channel opening frequency
B. The GABA binding site directly, mimicking GABA
C. The barbiturate site, prolonging chloride channel open duration
D. The NMDA receptor site, reducing glutamate excitotoxicity
Correct Answer: A
Rationale:
Benzodiazepines bind to a distinct allosteric site on the GABA-A receptor, increasing the frequency of chloride
channel opening when GABA is present, which hyperpolarizes the neuron and produces anxiolysis. They do not
bind the GABA site directly (that would be a direct agonist) nor the barbiturate site (which increases duration, not
frequency).
Q4 Question 4 of 100
A 55-year-old female with bipolar I disorder is started on lithium. Her PMHNP explains that lithium's therapeutic
mechanism most likely involves inhibition of which intracellular enzyme system?
A. Monoamine oxidase type A
B. Phosphodiesterase type 4
C. Inositol monophosphatase and GSK-3
D. Tyrosine hydroxylase
Correct Answer: C
Rationale:
Lithium inhibits inositol monophosphatase (depleting the phosphatidylinositol second-messenger pool) and glycogen
synthase kinase-3 (GSK-3), both of which modulate intracellular signaling cascades relevant to mood regulation.
Lithium does not inhibit MAO-A, PDE-4, or tyrosine hydroxylase.
Midterm
Midterm
Exam
Exam
NRNP6635
NRNP6635
/ NRNP
/ NRNP
6635
6635
(Latest
(Latest
2026/2027):
2026/2027):
Psychopathology
Psychopathology
andand
Diagnostic
Diagnostic
Reasoning
Reasoning
- Walden
- Walden
2026/2027
2026/2027
2026/2027
2026/2027
| Passing
| Passing
Score:
Score:
80%80%
| Page
| Page
4 of4 54